Skip to Content
Find MS events and support groups near you! Get started >>

Hydroxyzine Pregnancy and Breastfeeding Warnings

Hydroxyzine is also known as: Atarax, Hyzine, Rezine, Vistaril, Vistazine

Hydroxyzine Pregnancy Warnings

Hydroxyzine has not been formally assigned to pregnancy category by the FDA. Hydroxyzine has been assigned to pregnancy Risk Factor C by Briggs et al. Animal studies have revealed evidence of teratogenicity when given in high doses. There are no controlled data in human pregnancy. The manufacturer considers hydroxyzine to be contraindicated in early pregnancy due to lack of clinical data. Hydroxyzine is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

The Collaborative Perinatal Project monitored 50,282 mother-child pairs, of whom 50 were exposed to hydroxyzine during the first trimester. Five malformed children were reported suggesting a possible relationship between first trimester use and congenital defects. Data from the Michigan Medicaid Birth Defects Study revealed an association between the use of hydroxyzine and birth defects during the first trimester (personal communication. F. Rosa, MD, FDA, 1993). This was a retrospective study of 229,101 completed pregnancies between 1985 and 1992, of which 828 newborns were exposed to hydroxyzine during the first trimester. A total of 48 birth defects were observed (42 expected). The defects included cardiovascular, spina bifida, polydactyly, limb reduction defects, hypospadias, and oral clefts. Only with the latter is there a suggestion of a possible association, however, other factors such as the mother's disease, concurrent drug use, and chance, may be involved.

See references

Hydroxyzine Breastfeeding Warnings

There are no data on the excretion of hydroxyzine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. The drugs and pregnancy study group "Strategy of treatment of pruritus during pregnancy." Ann Pharmacother 28 (1994): 17-20
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  3. "Product Information. Vistaril (hydroxyzine)." Pfizer US Pharmaceuticals, New York, NY.

References for breastfeeding information

  1. "Product Information. Vistaril (hydroxyzine)." Pfizer US Pharmaceuticals, New York, NY.
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.